Result Summary for APV10026
| Protocol ID: | APV10026 |
| Clinical Study ID: | APV10026 |
| Official Title: | A Phase I, Open-Label, Single-Sequence, Drug-Drug Interaction Study Comparing Ketoconazole and Amprenavir Pharmacokinetics Following Administration of Ketoconazole 200 mg QD for Four Days, Fosamprenavir 700mg BID + Ritonavir 100mg BID for Ten Days, and Ketoconazole 200 mg QD + Fosamprenavir 700m ... |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | fosamprenavir |
| Trade/Product Name: | Telzer,Telzir,Lexiva |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
